DE3884878D1 - Uricosuretische Zusammensetzung. - Google Patents
Uricosuretische Zusammensetzung.Info
- Publication number
- DE3884878D1 DE3884878D1 DE88111996T DE3884878T DE3884878D1 DE 3884878 D1 DE3884878 D1 DE 3884878D1 DE 88111996 T DE88111996 T DE 88111996T DE 3884878 T DE3884878 T DE 3884878T DE 3884878 D1 DE3884878 D1 DE 3884878D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- uricosuretic
- uricosuric
- gout
- chem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18982287 | 1987-07-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3884878D1 true DE3884878D1 (de) | 1993-11-18 |
DE3884878T2 DE3884878T2 (de) | 1994-02-17 |
Family
ID=16247787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE88111996T Expired - Fee Related DE3884878T2 (de) | 1987-07-29 | 1988-07-26 | Uricosuretische Zusammensetzung. |
Country Status (8)
Country | Link |
---|---|
US (1) | US4931440A (de) |
EP (1) | EP0301466B1 (de) |
KR (1) | KR960014874B1 (de) |
AT (1) | ATE95697T1 (de) |
AU (1) | AU615932B2 (de) |
CA (1) | CA1336959C (de) |
DE (1) | DE3884878T2 (de) |
ZA (1) | ZA885358B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0747582B2 (ja) * | 1989-12-11 | 1995-05-24 | 杏林製薬株式会社 | キナゾリン―3―アルカン酸誘導体とその塩およびその製造法 |
US6339088B1 (en) | 1999-02-18 | 2002-01-15 | R-Tech Ueno. Ltd. | Composition for treatment of external secretion disorders except hypol acrimation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8524663D0 (en) * | 1985-10-07 | 1985-11-13 | Fujisawa Pharmaceutical Co | Quinazoline derivatives |
-
1988
- 1988-07-20 US US07/221,654 patent/US4931440A/en not_active Expired - Lifetime
- 1988-07-22 ZA ZA885358A patent/ZA885358B/xx unknown
- 1988-07-26 AT AT88111996T patent/ATE95697T1/de not_active IP Right Cessation
- 1988-07-26 EP EP88111996A patent/EP0301466B1/de not_active Expired - Lifetime
- 1988-07-26 DE DE88111996T patent/DE3884878T2/de not_active Expired - Fee Related
- 1988-07-27 CA CA000573187A patent/CA1336959C/en not_active Expired - Fee Related
- 1988-07-28 KR KR1019880009501A patent/KR960014874B1/ko not_active IP Right Cessation
- 1988-07-28 AU AU20138/88A patent/AU615932B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DE3884878T2 (de) | 1994-02-17 |
US4931440A (en) | 1990-06-05 |
ATE95697T1 (de) | 1993-10-15 |
AU615932B2 (en) | 1991-10-17 |
ZA885358B (en) | 1989-03-29 |
EP0301466B1 (de) | 1993-10-13 |
EP0301466A2 (de) | 1989-02-01 |
CA1336959C (en) | 1995-09-12 |
AU2013888A (en) | 1989-02-02 |
EP0301466A3 (en) | 1990-09-12 |
KR890001555A (ko) | 1989-03-27 |
KR960014874B1 (ko) | 1996-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO912410D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklen-derivater. | |
ES8707947A1 (es) | Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos. | |
NO163568C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater. | |
DK0453042T3 (da) | Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner | |
DE69215694D1 (de) | Benzamid-derivate | |
NO166938C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxyeddiksyrederivater. | |
ATE79257T1 (de) | Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden. | |
ZA89389B (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
NO168243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
NO881835L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser. | |
DE69001722D1 (de) | Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. | |
KR880007070A (ko) | 백내장 치료용 약학 조성물 | |
ATE38982T1 (de) | Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel. | |
ATE95697T1 (de) | Uricosuretische zusammensetzung. | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |